摘要
目的探讨联合接种乙型脑炎减毒活疫苗及水痘减毒活疫苗的安全性与可行性。方法将2016年4月~2017年8月接种疫苗的儿童180例作为研究对象,利用随机抽样原则将儿童分为Ⅰ、Ⅱ、Ⅲ组,每组60例。Ⅰ组儿童采取联合接种方式:水痘减毒活疫苗+乙脑减毒活疫苗;Ⅱ组儿童仅单独接种:乙型脑炎减毒活疫苗;Ⅲ组儿童仅单独接种:水痘减毒活疫苗。结果对儿童进行3个月随访,三组儿童在接种后的不同时间的总发热率比较,差异无统计学意义(P>0.05)。在随访的3个月内,三组接种疫苗的儿童均未出现水疱疹、过敏性休克、水痘样综合征以及血管水肿等不良反应。结论联合接种乙脑减毒活疫苗和水痘减毒活疫苗同单独接种疫苗比较,儿童的不良反应并无显著差异,联合接种疫苗的安全性较高,适合应用并推广。
Objective To investigate the safety and feasibility of simultaneous inoculation of live attenuated Japanese encephalitis vaccine and live attenuated varicella vaccine. Methods A total of 180 children vaccinated from April 2016 to August 2017 were selected as study objects. The children were divided into groups Ⅰ, Ⅱ, and Ⅲ by random sampling principle, and there were 60 children in each group. Children in group Ⅰ received a combined vaccination: live attenuated Japanese encephalitis vaccine and live attenuated varicella vaccine, while children in group Ⅱ received vaccination alone: live attenuated Japanese encephalitis vaccine, and children in group Ⅲ received only vaccination alone: live attenuated varicella vaccine. Results After 3 months of follow-up, there was no significant difference in the total fever rate at different time after inoculation in children among three groups(P>0.05). During the follow-up period of 3 months, there were no adverse reactions such as herpes zoster, anaphylactic shock, varicella syndrome and angioedema in the three groups of vaccinated children. Conclusion Compared with individual vaccinations, there was no significant difference in children′s adverse reactions compared with the combined live attenuated Japanese encephalitis vaccine and live attenuated varicella vaccine compared with vaccine alone. The safety of the combined vaccination was higher and it was suitable for application and promotion.
引文
[1]尹志英,龚晓英,来时明,等.吸附无细胞百白破联合疫苗加强免疫与水痘减毒活疫苗联合接种的效果观察[J].中国疫苗和免疫,2017,23(2):182-186.
[2]杨利伟,栾春芳,干玲玲,等.水痘减毒活疫苗(SV-1细胞)的大鼠长期毒性试验[J].中国生物制品学杂志,2017,30(1):5-10.
[3]周俏梅.社区儿童乙脑减毒活疫苗接种的综合护理[J].中国医药指南,2015,13(5):237-238.
[4]黄腾,司国爱,李长贵,等.国产和进口冻干水痘减毒活疫苗两针免疫程序在12岁以上中国健康人群中的安全性和免疫原性比较[J].中国生物制品学杂志,2016,29(6):610-615.
[5]叶青.乙脑减毒活疫苗关键功能位点分析及相关病毒载体应用研究[D].北京:解放军军事医学科学院,2015.
[6]周方,俞华,赵德峰.接种乙脑减毒活疫苗引起小脑共济失调一例报告[J].公共卫生与预防医学,2014,25(4):108-109.
[7]黄怡微,林天海,杨波,等.乙脑减毒活疫苗两针法免疫效果观察[J].海峡预防医学杂志,2015,21(1):39-41.
[8]黄峰,谢琳,易婷.乙脑减毒活疫苗接种不良反应的观察及护理[J].基层医学论坛,2013,17(36):4866-4867.
[9]刘正林.邓州市一例接种乙脑减毒活疫苗特异异常反应的报告[J].求医问药(下半月),2012,10(3):513-514.
[10]胡正伟.接种麻风与乙脑减毒活疫苗致急性荨麻疹一例报告[J].赣南医学院学报,2010,30(6):908.
[11]杨立清,李丽,张楠,等.水痘疫苗2剂接种程序对北京市朝阳区水痘发病的影响[J].中国生物制品学杂志,2015,28(11):1177-1179,1182.
[12]董芳芳,陈宝丽,王燕云,等.营养干预对轻度子痫前期患者24 h尿蛋白定量的影响研究[J].标记免疫分析与临床,2016,23(2):161-163.
[13]石昭俊.甲氰咪胍治疗小儿水痘52例观察[J].铁道医学,1995,23(4):245.
[14]富继业,史如晶,马天薇,等.水痘减毒活疫苗高覆盖率的托幼机构水痘爆发调查[J].中国疫苗和免疫,2015,21(1):80-83,118.
[15]黄建生,黄建萍.万乃洛韦治疗儿童水痘临床疗效观察[J].中国现代医学杂志,2003,13(17):138-139.
[16]黄友敏,刘松华.乙型脑炎病毒感染患儿血清中IL-12和IL-18的含量变化[J].标记免疫分析与临床,2003,10(3):185-186.
